SCHEMBL18540707

SCHEMBL18540707

O=POc1cccc(C(=O)c2cccc(Br)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.47
▸ STS P08842 5/20 0.45
▸ MAOB P27338 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MRGPRX4 Q96LA9 1/20 0.41
▸ HPGD P15428 3/20 0.41
▸ LMNA P02545 1/20 0.41
▸ GAA P10253 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3839214 0.81 AKR1C3 (0.53) PARP1STSMAOBALDH1A1TP53
SCHEMBL18540709 0.81 STS (0.53) PARP1STSMAOBALDH1A1TP53
SCHEMBL30153175 0.80 PARP1 (0.68) PARP1MAOBALDH1A1TP53KMT2A
SCHEMBL241785 0.80 PARP1 (0.68) PARP1MAOBALDH1A1TP53KMT2A
SCHEMBL30136061 0.80 CES2 (0.62) PARP1STSKMT2AHPGDLMNA
SCHEMBL4238012 0.80 CES2 (0.62) PARP1STSKMT2AHPGDLMNA
SCHEMBL18529822 0.79 SRC (0.47) PARP1STSMAOBALDH1A1TP53
Hydrochloric Acid SCHEMBL27869733 0.78 PARP1 (0.65) PARP1MAOBALDH1A1TP53KMT2A
SCHEMBL9178374 0.78 AKR1C3 (0.61) KMT2AMRGPRX4
SCHEMBL21629500 0.77 CTSL (0.61) PARP1STSMAOBALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017030983-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF CATHEPSINS MATEON THERAPEUTICS, INC. (US) 2017-02-23 — — WO disclosed
Send feedback